# Janssen Research & Development – FDA Inspection, Jun 14, 2024

Source: https://www.keypedia.com/records/fda_inspections/janssen-research-development/0b6e6ed2-dbb3-4cbf-bb24-b14cb87ea48f
Source feed: FDA_Inspections

> FDA inspection 1245603 of Janssen Research & Development, June 14, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1245603
- Company Name: Janssen Research & Development
- Inspection Date: 2024-06-14
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/sri-rama-kr-yellela/b579e7ba-855b-4a15-b0fb-35bf33562d09)

Company: https://www.keypedia.com/companies/janssen-research-development/792375f6-4f1e-4806-bc2b-29f46c198aa6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c